253662 New Era of Tobacco Control Working With the FDA

Tuesday, November 1, 2011: 11:10 AM

Amber Thornton Bullock, MPH, CHES , Program Development, American Legacy Foundation, Washington, DC
Now that the Family Smoking Prevention and Tobacco Control Act is the law of the land, the tobacco control community must navigate a whole new area of government that they have had little involvement with in the past: the federal regulatory process. This presentation will discuss the importance of involvement in the process by tobacco control practitioners, academics and researchers, as well as address the basics of the regulatory process and how to participate. Two major issues in tobacco control regulation, Menthol and Graphic Warning Labels, will be used as case studies where scientific and academic, as well as on-the-ground expertise created the building blocks upon which FDA made and continues to make decisions in those areas.

As the implementation of the Family Smoking Prevention and Tobacco Control Act continues, participants will learn the basis of how the federal regulatory process works, and why they should participate in the process.

Learning Areas:
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Define the various stages of the regulatory process. Identify areas in which the FDA might best participate in the regulatory process. Evaluate the FDA's expertise in order to provide the most relevant information to them as they implement the Tobacco Control Act.

Keywords: FDA, Tobacco Legislation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have relevant managerial experience on tobacco control issues related to the topic I am presenting on. I have worked on tobacco control issues for the past twenty plus years. The mission of the American Legacy Foundation is to build a world where youth reject tobacco and anyone can quit. We have been very engaged on issues related to regulatory aspects of tobacco control.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.